Humans are the only natural reservoir of measles virus (MV), one of the most contagious viruses known. MV infection and the profound immunosuppression it causes are currently responsible for nearly one million deaths annually. Human signaling lymphocytic activation molecule (hSLAM) was identified as a receptor for wild-type MV as well as for MV strains prepared as vaccines. To better evaluate the role of hSLAM in MV pathogenesis and MV-induced immunosuppression, we created transgenic (tg) mice that expressed the hSLAM molecule under the control of the lck proximal promoter. hSLAM was expressed on CD4؉ and CD8 ؉ T cells in the blood and spleen and also on CD4 Since measles virus (MV) was isolated and attenuated to produce a successful vaccine (7,20), it was shown to cause a progressive central nervous system (CNS) disease (subacute sclerosing panencephalitis) and was found to be capable of suppressing immune responses (28, 53).More recently, two developments have aroused interest in the nature of MV. The first was the discovery of two cell surface receptors for MV, namely, the CD46 molecule, which is a member of the complement regulatory cascade of proteins (6,26,33), and signaling lymphocytic activation molecule (SLAM), a T-cell costimulatory molecule (9, 18, 52). Whereas the CD46 molecule is ubiquitously expressed on all nucleated cells, SLAM is expressed only on immature thymocytes, activated and memory T cells, B cells, and activated monocytes and dendritic cells (4,29,30,40,49). The second development was a better understanding of mechanisms of MV-induced immunosuppression. Although the route of infection by MV is respiratory, and despite its widespread dissemination to the skin, the intestinal tract, and the nervous system, the virus has a strong predilection for lymphoid tissues in the early as well as late stages of the disease. Furthermore, lymphoid tissues and cells provide not only a replication site but also a means of transporting the virus within the body. Since both CD46, constitutively, and SLAM, inducibly, are concomitantly present on cells of the human immune system, the relative individual contribution of either of the two MV receptors in MV-induced immunosuppression has been difficult to sort out. MV has been known to induce mitogen unresponsiveness of T cells by direct infection and contact with infected cells (12,43,56). However, the lack of a suitable small-animal model has impeded progress toward understanding the pathogenic effects of MV, especially its ability to induce immunosuppression, a CNS disease, and virus-immune cell and virus-neuron interactions. Following the identification of MV receptor CD46, investigators in several laboratories have attempted to express human CD46 in transgenic (tg) mice as models that could be infected by MV (16,36,41,57). The human CD46 protein has a 45% homology with mouse CD46 (54). Mice are not infected by MV unless the virus has been adapted to the murine cells by multiple passages (24) or unless human CD46 is expressed in the mouse. In terms of under...